Subscription Required

Only paid subscribers* to Specialty Pharmacy News can access this Web portal with three years of back issues, searchable article archives and other valuable resources.

Subscribers to Specialty Pharmacy News receive

  • 12 monthly issues packed with news and strategies on this increasingly vital sector in health business, delivered First Class by U.S. Mail and electronically (optional),
  • E-News Alerts whenever important news breaks, and
  • Access to a subscriber-only Web page with:
    • Searchable archives of past articles,
    • Convenient library with PDFs of back issues,
    • Recent stories of interest and hot topic articles grouped for convenient reading, and
    • Regular postings from Managing Editor Angela Maas.
View a sample and get more information
May 2015

Recent Stories of Interest

From Specialty Pharmacy News - Almost seven years after accepting an application for a generic version of Teva Pharmaceutical Industries Ltd.’s 20 mg/mL Copaxone (glatiramer acetate), the FDA finally on April 16 approved Sandoz Inc./Momenta Pharmaceuticals, Inc.’s Glatopa to treat multiple sclerosis (MS). The companies developed the drug together, and Sandoz will market it. With many industry experts expecting the new competitor to be priced at about 30% less than Copaxone, the approval couldn’t have come fast enough: Read more

Interest in the pharmacy sector shows no signs of waning, as yet… Read more

In a move that took many industry experts by surprise, OptumRx said… Read more

As of June 1, Aetna Inc. will shift almost all of its… Read more

From the Editor

Welcome to your Specialty Pharmacy News subscriber-only Web page

Be sure to visit often, for PDFs of issues, archives of articles and data, and more!

Please e-mail me with your comments on the last issue of Specialty Pharmacy News, story ideas for future issues, or any other suggestions you have that can make the newsletter more useful for you.

May 21, 2015
Meijer Says It Will Buy Aureus

Supercenter and grocery store retailer Meijer says it will acquire specialty pharmacy Aureus Health Services; Aureus CEO Mike Nameth will remain in that role

April 16, 2015
FDA Approves First Generic Copaxone for MS

The FDA approved Sandoz’s Glatopa, the first generic version of Teva’s multiple sclerosis treatment Copaxone (glatiramer acetate) in a 20 mg/ml once-daily injection

April 6, 2015
New EMD Serono Specialty Digest Released

EMD Serono releases 11th edition of its Specialty Digest; plans cite managing oncology, determining a therapy’s value as top specialty drug management challenges

Updated Regularly

Featured Hot Topics

Search for your own Hot Topics

It's quick and easy to sign up for FREE access to!

Why do I need to register?